tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rigel Pharmaceuticals reports Q2 EPS $3.91, consensus $1.40
PremiumThe FlyRigel Pharmaceuticals reports Q2 EPS $3.91, consensus $1.40
1M ago
Rigel Pharmaceuticals (RIGL) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Rigel Pharmaceuticals (RIGL) Q2 Earnings Cheat Sheet
1M ago
Eli Lilly and Rigel Pharmaceuticals: Promising Advances in Rheumatoid Arthritis Treatment
Premium
Company Announcements
Eli Lilly and Rigel Pharmaceuticals: Promising Advances in Rheumatoid Arthritis Treatment
2M ago
Rigel Pharmaceuticals Reports Strong Growth and Strategic Advances
PremiumCompany AnnouncementsRigel Pharmaceuticals Reports Strong Growth and Strategic Advances
4M ago
Rigel’s Strong Q1 Performance and Strategic Focus Bolster Buy Rating
Premium
Ratings
Rigel’s Strong Q1 Performance and Strategic Focus Bolster Buy Rating
4M ago
Rigel Pharmaceuticals Reports Strong Q1 2025 Earnings
Premium
Company Announcements
Rigel Pharmaceuticals Reports Strong Q1 2025 Earnings
4M ago
Rigel Pharmaceuticals Appoints Dr. Frohlich to Board
PremiumCompany AnnouncementsRigel Pharmaceuticals Appoints Dr. Frohlich to Board
6M ago
Rigel Pharmaceuticals price target raised to $55 from $49 at Citi
Premium
The Fly
Rigel Pharmaceuticals price target raised to $55 from $49 at Citi
6M ago
Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal
Premium
Company Announcements
Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100